person

Andri P.

Country
Sweden
Department
Medicinsk Enhet Bröst-, endokrina tumörer och sarkom

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
2
Sites with multiple studies

Has run more than one trial at 2 of 12 partner sites.

Specializations

Gastrointestinal Oncology

The investigator specializes in the treatment of gastrointestinal stromal tumors (GIST), exploring innovative therapeutic approaches in this field. Their research encompasses combination therapy strategies for patients with GIST, particularly focusing on targeted treatment modalities.

  • GIST Treatment Optimization
  • Combination Therapy Approaches
  • Targeted Therapeutic Strategies

Their work involves evaluating novel therapeutic combinations to enhance treatment outcomes for GIST patients.

Soft Tissue Sarcomas

The investigator conducts research in advanced dedifferentiated liposarcoma (DDLPS), focusing on innovative treatment approaches. Their expertise extends to exploring immunotherapy and targeted therapy combinations for this rare form of soft tissue sarcoma.

  • Liposarcoma Management
  • Immunotherapy Applications
  • Advanced Sarcoma Treatment

Their research aims to advance therapeutic options for patients with advanced DDLPS through novel drug combinations.

Clinical Innovation

The investigator's work encompasses developing targeted therapeutic strategies for rare oncological conditions. Their research focuses on evaluating novel drug combinations and investigating innovative treatment approaches for challenging cancer types.

  • Novel Drug Combinations
  • Rare Cancer Treatment
  • Treatment Innovation

Their expertise includes evaluating therapeutic efficacy in complex oncological conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.